Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|
MCF 10A | 0 | uM | 9 | 156.25 | 46.09 | 226.00 | 237.25 | 0.9526 | 0.9593 | |
MCF 10A | Erlotinib | 0.0033113 | uM | 9 | 156.25 | 46.09 | 315.00 | 237.25 | 1.3277 | 1.2548 |
MCF 10A | 17-AAG | 0.001 | uM | 9 | 156.25 | 46.09 | 305.00 | 237.25 | 1.2856 | 1.2242 |
MCF 10A | 17-AAG | 0.000066069 | uM | 9 | 156.25 | 46.09 | 273.00 | 237.25 | 1.1507 | 1.1223 |
MCF 10A | Linsitinib | 3.1623 | uM | 9 | 156.25 | 46.09 | 72.00 | 237.25 | 0.3035 | 0.2077 |
MCF 10A | Erlotinib | 19.9526 | uM | 9 | 156.25 | 46.09 | 31.00 | 237.25 | 0.1307 | -0.1545 |
MCF 10A | Lapatinib | 0.1 | uM | 9 | 156.25 | 46.09 | 367.00 | 237.25 | 1.5469 | 1.4054 |
MCF 10A | Lapatinib | 0.0016596 | uM | 9 | 156.25 | 46.09 | 438.00 | 237.25 | 1.8462 | 1.5922 |
MCF 10A | 0 | uM | 9 | 156.25 | 46.09 | 372.00 | 237.25 | 1.5680 | 1.4192 | |
MCF 10A | 17-AAG | 0.1 | uM | 9 | 156.25 | 46.09 | 32.00 | 237.25 | 0.1349 | -0.1430 |
MCF 10A | Erlotinib | 0.1 | uM | 9 | 156.25 | 46.09 | 394.00 | 237.25 | 1.6607 | 1.4787 |
MCF 10A | Lapatinib | 0.31623 | uM | 9 | 156.25 | 46.09 | 350.00 | 237.25 | 1.4752 | 1.3576 |
MCF 10A | Linsitinib | 0.31623 | uM | 9 | 156.25 | 46.09 | 245.00 | 237.25 | 1.0327 | 1.0274 |
MCF 10A | Lapatinib | 0.01 | uM | 9 | 156.25 | 46.09 | 382.00 | 237.25 | 1.6101 | 1.4465 |
MCF 10A | Linsitinib | 0.031623 | uM | 9 | 156.25 | 46.09 | 330.00 | 237.25 | 1.3909 | 1.2996 |
MCF 10A | Erlotinib | 0.031623 | uM | 9 | 156.25 | 46.09 | 290.00 | 237.25 | 1.2223 | 1.1773 |
MCF 10A | Erlotinib | 1 | uM | 9 | 156.25 | 46.09 | 52.00 | 237.25 | 0.2192 | 0.0524 |
MCF 10A | 17-AAG | 0.000302 | uM | 9 | 156.25 | 46.09 | 238.00 | 237.25 | 1.0032 | 1.0027 |
MCF 10A | Lapatinib | 3.1623 | uM | 9 | 156.25 | 46.09 | 143.00 | 237.25 | 0.6027 | 0.6144 |
MCF 10A | 17-AAG | 0.31623 | uM | 9 | 156.25 | 46.09 | 36.00 | 237.25 | 0.1517 | -0.0993 |
MCF 10A | 0 | uM | 9 | 156.25 | 46.09 | 288.00 | 237.25 | 1.2139 | 1.1709 | |
MCF 10A | 0 | uM | 9 | 156.25 | 46.09 | 228.00 | 237.25 | 0.9610 | 0.9666 | |
MCF 10A | Linsitinib | 1 | uM | 9 | 156.25 | 46.09 | 63.00 | 237.25 | 0.2655 | 0.1414 |
MCF 10A | Erlotinib | 0.31623 | uM | 9 | 156.25 | 46.09 | 116.00 | 237.25 | 0.4889 | 0.4777 |
MCF 10A | 0 | uM | 9 | 156.25 | 46.09 | 276.00 | 237.25 | 1.1633 | 1.1322 |